The US Department of Health and Human Services (HHS) has provided Moderna with a $590 million investment to hasten the development of an mRNA-based avian flu vaccine. This move aims to bolster global preparedness in case of a potential pandemic caused by the lethal bird flu virus.
Tag: vaccine development
Moderna Secures 590 Million Dollars for Accelerated Development of mRNA Bird Flu Vaccine
Moderna, a leading biotechnology company, has received a substantial financial boost from the US Department of Health & Human Services (HHS) to speed up the development of an mRNA-based vaccine for bird flu. The award amounts to approximately 590 million dollars, fueling research and production efforts to combat the potential outbreak of a human pandemic.